(NASDAQ: SOPH) Sophia Genetics Sa's forecast annual revenue growth rate of 17.63% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.92%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Sophia Genetics Sa's revenue in 2025 is $67,173,000.On average, 1 Wall Street analysts forecast SOPH's revenue for 2025 to be $4,991,566,125, with the lowest SOPH revenue forecast at $4,991,566,125, and the highest SOPH revenue forecast at $4,991,566,125. On average, 1 Wall Street analysts forecast SOPH's revenue for 2026 to be $6,401,499,796, with the lowest SOPH revenue forecast at $6,401,499,796, and the highest SOPH revenue forecast at $6,401,499,796.
In 2027, SOPH is forecast to generate $7,239,775,526 in revenue, with the lowest revenue forecast at $7,239,775,526 and the highest revenue forecast at $7,239,775,526.